Chapters

Transcript

Video

Given the long-term sequelae of supra-physiologic dosing of glucocorticoids for CAH, what therapeutic strategies are being considered to uncouple the cortisol and androgen pathways?

Given the long-term sequelae of supra-physiologic dosing of glucocorticoids for CAH, what therapeutic strategies are being considered to uncouple the cortisol and androgen pathways?


Created by

CMEducation Resources | iQ&A Congenital Adrenal Hyperplasia (CAH) Medical Intelligence Zone 

Presenter

Ellen Seely, MD

Ellen Seely, MD

Vice Chair, Faculty Development
Department of Medicine
Director of Clinical Research, Endocrinology, Diabetes and Hypertension Division
Brigham & Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, MA